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Background/aim: To document the safety, success, and complications of transradial coronary procedures.
Materials and methods: This retrospective study consisted of 427 patients who had undergone transradial coronary angiography and/or
angioplasty between June 2010 and May 2012. The main outcome measures were the procedural safety, success rate, and complications
associated with transradial interventions.
Results: Procedural success rate was 93.2% (398/427), with cannulation time of 2.1 ± 1.4 min, diagnostic time of 5.6 ± 2.1 min,
fluoroscopy time of 9.5 ± 6.6 min, and total procedure time of 47.1 ± 20.2 min. The main causes for unsuccessful procedures were failed
radial puncture (11 patients), serious radial artery spasm (12 patients), and distinct tortuosity (5 patients) and severe proximal stenosis
(1 patient) of the right subclavian artery. Of 398 patients, 345 (86.7%) underwent both coronary angiography and angioplasty, while the
remaining 53 (13.3%) had coronary angiography only. Major complication was recorded in only 1 patient (transient ischemic attack),
whereas minor complications were observed in 76 patients (17 with symptomatic sinus bradycardia, 12 with venous thrombosis, 22 with
hematoma, and 25 with radial artery occlusion).
Conclusion: Our experience revealed that the transradial approach is a safe and feasible method for coronary procedures in patients
with various manifestations of coronary disease.
Key words: Radial artery, coronary disease, angiography, angioplasty

1. Introduction
Coronary angiography (CAG) and percutaneous coronary
intervention (PCI) have been conventionally performed
via the transfemoral approach (TFA). The size of the
femoral artery has been regarded as the most crucial factor
in preferring this localization for access, and in particular
for the use of large diameter diagnostic and guiding
catheters and balloons. Other advantages of the TFA are
that it allows optimal catheter manipulation, the use of
other devices such as an intraaortic balloon pump (IABP),
and coronary or aortic valve interventions requiring
greater than 7 F catheters. However, there are some
complications that limit the use of femoral access points,
such as hematoma, serious blood loss, pseudoaneurysm,
and arteriovenous fistula. These complications may be
especially more serious owing to the use of antiaggregants
and anticoagulants, such as acetylsalicylic acid (ASA),
heparin, and glycoprotein (Gp) IIb/IIIa inhibitors in
the setting of acute coronary syndrome (ACS) (1–3).
* Correspondence: mustafayurtdas@yahoo.com
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Compared with the TFA, the transradial approach (TRA)
is associated with fewer access point complications,
shorter hospital stay, and better quality of care after the
procedure. The safety and feasibility of this procedure
have been reported in great numbers of clinical studies
(4–7). However, little is known about angiographies and/
or angioplasties performed through the TRA in Turkey. In
the present trial, we aimed to report the procedural safety,
success, and complications related to the transradial CAG
and PCI applied in 2 different cardiology clinics.
2. Materials and methods
2.1. Patient population
Among 2164 consecutive patients who had undergone
CAG and/or PCI via both the femoral and radial
approaches between June 2010 and May 2012 in 2
cardiology clinics, 427 had coronary procedures that
had been performed using the only TRA. Indications for
CAG and/or PCI were significant symptomatic angina,
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abnormal stress test or myocardial perfusion scan, and
ACS, including acute myocardial infarction (AMI). All
ACS patients had received 300 mg of ASA and 600 mg of
clopidogrel in the emergency department, as well as an
intravenous (iv) bolus of unfractionated heparin (UFH)
(5000 IU). In the catheterization room, an additional iv
bolus of 5000 IU of UFH was delivered into the sheath
immediately after arterial cannulation. Some patients
with excessive thrombotic burden were administered
an intracoronary bolus of Gp IIb/IIIa platelet inhibitor
(tirofiban) followed by an iv infusion for at least 12 h
after PCI. Some of the patients with AMI had a history
of prehospital administration of fibrinolytic therapy. The
study protocol was carried out according to the principles
of the Declaration of Helsinki and was approved by the
Investigational Review Board of the Kafkas University
School of Medicine.
2.2. Clinical assessment
The clinical and angiographic data of 427 patients were
reviewed retrospectively. All patients underwent routine
history and clinical examination. Clinical and oxymetric
Allen tests were carried out for the assessment of dual
arterial supply to both hands. Exclusion criteria for the
transradial approach were an abnormal Allen test, chronic
kidney disease (creatinine of ≥2.0 mg/dL) requiring
dialysis (to avoid any injury to the forearm circulation),
absence of the radial pulse, and previous brachial cutdown. Radial artery access was the default approach in
unselected patients undergoing coronary procedures.
Left rad al access was the default approach in patients
with previous coronary artery bypass grafting using a left
internal mammary artery.
2.3. Sheath placement and hemostasis
After local anesthesia with 1 mL of 2% lidocaine and 1
mL of nitroglycerine, the radial artery was punctured with
a metal needle of 20G×1½˝, and a straight guidewire of
0.025˝ was inserted through the needle. Upon removal of
the needle, a 16-cm 6 F sheath (Radifocus Introducer II,
Terumo Europe, Belgium) was placed over the guidewire.
To reduce spasm and to prevent thrombosis, intraarterial
drugs such as nitroglycerine (200 to 400 µg), verapamil or
diltiazem (1 to 2.5 mg), and UFH (5000 IU) were routinely
given through the sheath. CAG and PCI were performed
using 6 F diagnostic (Cordis Corporation) and 6 F guiding
catheters manufactured by either Boston Scientific/Scimed
(Maple Grove, MN, USA) or Medtronic (Maple Grove, MN,
USA), respectively. After completion of the procedure, the
radial sheath was immediately removed, and hemostasis
was achieved by local compression for an average of 10
min, followed by an adhesive pressure bandage for an
average of 3 h. All patients were encouraged to attempt
early ambulation. All procedures were performed by 2
interventional cardiologists with significant experience

(annual transradial coronary procedures [angiography
and angioplasty] volume ranged from 15% to 45% of total
annual coronary procedures volume for 2 operators).
2.4. Operational definitions
Radial artery cannulation time was described as the time
from infiltration of lidocaine to radial sheath placement.
The diagnostic time was described as the time from
radial sheath placement to termination of bilateral
CAG. Fluoroscopy time was defined as the total time
of fluoroscopy use during the CAG and/or PCI. Total
procedure time was defined as the time from infiltration
of local anesthesia to finalizing of bilateral CAG and/or
PCI. Procedural success was described as the completion
of a transradial coronary procedure (angiography and/or
angioplasty). The duration of cannulation was defined as
the time from radial sheath placement to the decannulation
of the radial sheath. Vascular spasm was described as the
resistance between the radial artery and the equipment
used (8). Access site bleeding was described according to
Thrombolysis in Myocardial Infarction criteria (9). Radial
artery occlusion (RAO) was defined as the absence of
palpable radial pulsation verified by a negative Allen test,
and/or visible obstruction on 2-dimensional ultrasound,
and/or the absence of a Doppler flow signal at or distal to
the original access site (10).
Complications were described as minor (spasm,
hematoma of >5 cm, symptomatic sinus bradycardia
and/or atrioventricular block, RAO, venous thrombosis,
aneurysm, and arteriovenous fistulae) and major (death
caused by vascular injury, transient ischemic attack
(TIA), stroke, need for blood transfusion or a decrease
in hemoglobin of >3 g/dL due to vascular bleeding, and
major vascular occlusion, such as of the brachial artery).
2.5. Statistical analysis
The data obtained were analyzed by the SPSS 20 (IBM).
Continuous variables were presented as mean value ±
standard deviation (SD), and categorical variables were
shown as percentages.
3. Results
Clinical and demographic features of all patients are
detailed in Table 1. The trial population comprised 146
females (34.2%) and 281 males (65.8%) with a mean age
of 52.8 ± 9.4 years. Out of 427 patients, 263 (61.6%) had
stable angina pectoris (SAP), 83 (19.4%) had unstable
angina pectoris (USAP), 19 (4.5%) had non-Q MI, and 57
(13.3%) had acute ST elevation MI (STEMI); (confirmed
by marked symptoms, laboratory and electrocardiographic
findings, and exercise test and/or myocardial perfusion
scan results). The remaining 5 patients (1.17%) had
evaluation of coronary anatomy before mitral and/or
aortic valve surgery. The success rate of the TRA was
93.2% (398/427). The access sites and procedure failures
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Table 1. Clinical and demographic features of the overall study population.
Number of patients, n

427

Age, mean years ± SD

52.8 ± 9.4

Sex (female), n (%)

146 (34.2)

BMI (kg/m2)

29 ± 5

Risk factors, n (%)


Smoking

105 (24.6)



Hypertension

150 (35.1)



Hyperlipidemia

176 (41.2)



Diabetes mellitus

58 (13.6)



Family history

60 (14.1)

Clinical presentation, n (%)


SAP and/or inducible ischemia

263 (61.6)



Unstable angina

83 (19.4)



Non-Q MI

19 (4.5)



STEMI

57 (13.3)



Valvulopathy (mitral and/or aortic valve disease)

5 (1.17)

Previous percutaneous coronary intervention

62 (14.5)

Previous coronary artery surgery

13 (3.0)

Previous prosthetic heart valve operation


Mitral position

6 (1.41)



Aortic position

4 (0.94)



Both positions

2 (0.47)

BMI, body mass index; SAP, stable angina pectoris; Non-Q MI, non-Q wave myocardial
infarction; STEMI, ST elevation myocardial infarction.

in the total study population are shown in Table 2. The
main reasons for procedural failure involved failed radial
puncture in 11 patients (7 SAP, 3 USAP, 1 STEMI), severe
radial artery spasm in 12 patients (9 SAP, 1 USAP, 1 non-Q
MI, 1 STEMI), and marked tortuosity (5 patients) and
tight proximal stenosis (1 patient) of the right subclavian
artery in 6 patients with SAP, hindering the reaching of the
guidewire and/or catheter into the ascending aorta (Figures
1A and 1B). Among the 29 patients who experienced first
access failure, the second approach was a femoral artery in
18 (4.2%) cases (16 SAP, 2 USAP) and an ipsilateral ulnar
artery in the other 11 (2.6%) cases (6 SAP, 2 USAP, 1 non-Q
MI, and 2 STEMI). All attempts for the ulnar and femoral
arteries were successful. Thus, of these 398 patients with
successful transradial procedure, 345 (86.7%) had received
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both CAG and PCI, while the remaining 53 (13.3%) had
received CAG only, based on whether coronary artery
stenosis was significant or not. Gp IIb/IIIa inhibitors
were administered to 34 USAP, 8 non-Q MI, and 42 AMI
patients during the interventional procedures according
to the operator’s decision. Left radial artery cannulation
was applied successfully in all of the 13 patients who had
coronary artery bypass surgery with left internal mammary
artery graft. In the total study population, the radial artery
cannulation time was 2.1 ± 1.4 min, the diagnostic time
5.6 ± 2.1 min, the fluoroscopy time 9.5 ± 6.6 min, total
procedure time 47.1 ± 20.2 min, the mean duration of
cannulation 22 ± 5.6 min, and the mean length of stay in
hospital 11.6 ± 8.5 h (Table 3). Vascular complications are
depicted in Table 4. There were no major complications
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Table 2. Vascular accesses and procedures failures in the total study population.
Primary arterial vascular access, n (%)


Right radial artery

408 (95.5)



Left radial artery

19 (4.5)

Failure of primary vascular access, n (%)

29 (6.8)



With crossover to ipsilateral ulnar artery

11 (2.6)



With crossover to femoral artery

18 (4.2)

Reasons for procedural failure, n (%)


Failed radial puncture

11 (2.6)



Radial artery spasm

12 (2.8)



Subclavian artery tortuosity

5 (1.2)



Subclavian artery stenosis

1 (0.23)

Figure 1. Extreme tortuosity (A) and severe proximal stenosis (B) of the right subclavian
artery interrupting the reach of the catheter into the ascending aorta.

throughout the whole study, except for 1 patient (47
years old) with minimal coronary artery disease (CAD),
in whom TIA developed soon after the right TRA and
spontaneously ceased within seconds. Computed
tomography (CT) and diffusion magnetic resonance
imaging (MRI) of the brain showed no pathology for
this patient. In addition, while no atrioventricular block
was observed, sinus bradycardia developed in 17 (4.3%)
patients (for this condition, appropriate doses of atropine
were administered intravenously) during and/or a very
short time after the radial artery cannulation. Within
1 and 30 days after the transradial cardiac procedure, a
2-dimensional and Doppler ultrasonography assessment
of 59 (14.8%) patients who presented with pain,
edema, and rigidness in the right forearm was applied,
showing minor hematoma in 22 (5.5%) patients, venous

thrombosis of the right upper extremity in 12 (3.0%)
patients, and RAO in 25 (6.3%) patients. All these minor
complications were treated conservatively. Neither an
aneurysm nor a fistula was detected. After a followup period of 3–6 months, 11 patients with successful
transradial PCI were admitted to our clinic again due
to some symptoms such as chest pain and dyspnea. We
successfully performed repetitive transradial coronary
procedures in 7 patients who had positive exercise test
and/or myocardial scintigraphy results (CAG only in 3
patients, both CAG and PCI in 4 patients [new single
LAD lesion in 3 patients, restenotic single Cx lesion in 1
patient; radial cannulation time 2.3 ± 1.6 min, diagnostic
time 4.8 ± 1.8 min, fluoroscopy time 5.7 ± 2.6 min, total
procedure time 18.1 ± 12.7 min). Complications were not
observed in any of these patients.
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Table 3. Data regarding transradial angiography and angioplasty.
Number of patients with successful transradial procedures, n

398

Diagnostic coronary angiography only, n (%)

53 (13.3)

Both coronary angiography and angioplasty, n (%)

345 (86.7)

Single-vessel PCI, n (%)

303 (76.1)

Two-vessel PCI, n (%)

28 (7)

Three-vessel PCI, n (%)

12 (3)

Use of Gp IIb/IIIa inhibitors, n (%)

84 (21.1)

Cannulation time (min)

2.1 ± 1.4

Diagnostic time (min)

5.6 ± 2.1

Total procedure time (min)

47.1 ± 20.2

Fluoroscopy time (min)

9.5 ± 6.6

The duration of cannulation (min)

22 ± 5.6

The length of hospital stay (h)

11.6 ± 8.5

PCI, percutaneous coronary intervention; Gp, glycoprotein.
Table 4. Complications in patients with coronary procedures successfully
performed via transradial approach.
Minor complications, n (%)


Venous thrombosis

12 (3.0)



Hematoma

22 (5.5)



Radial artery occlusion

25 (6.3)



Symptomatic sinus bradycardia

17 (4.3)



Atrioventricular block

-



Aneurysm

-



Arteriovenous fistulae

-

Major complications, n (%)


Death

-



Blood transfusions

-



Major vascular occlusion

-



Transient ischemic attack

1 (0.25)



Stroke

-

4. Discussion
Our results showed that the TRA for CAG and/or PCI is a
safe method with high success rates, as well as low vascular
and access site complications. As far as we know, this is
the first study to demonstrate the feasibility and clinical
applicability of the TRA in patients with a wide range of
CAD, including AMI, in Turkey.
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The TRA for the diagnosis and treatment of CAD has
been successfully used in many cardiology clinics over
the past 20 years, since its introduction by Campeau, who
was the first to perform diagnostic catheterization in 1989
(11), and later by Kiemeneij and Laarman, who were the
first to report successful coronary stent implantation in
1993 through the TRA (12). The first data regarding this
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issue in Turkey come from a case published in 1996, in
which Yalçınkaya et al. reported successful implantation of
a coronary stent to the left anterior descending artery via
the TRA in a 65-year-old male patient (13). Yiğit et al. then
presented the first randomized trial comparing transradial
and transfemoral diagnostic CAG in Turkey, and they
concluded that the radial approach is as safe as the femoral
approach, with a procedural success rate of 85.2% in the
TRA group (4). The data available show that the success
rate for transradial coronary interventions has increased
in parallel with experience, in which the failure rate could
be diminished from 10% to 1% after 1000 cases (7,14,15).
Our procedural success rate was 93.2%, and this rate is
consistent with the success rates of 94%–98% reached in
some centers (5,7). In addition, the TRA was found to
be associated with a low crossover or failure rate in our
study. It was necessary to switch to either a femoral artery
or an ipsilateral ulnar artery in only 29 patients (6.8%)
by virtue of serious radial spasm, subclavian tortuosity,
and failed radial puncture. The failure or crossover rate
was expressed as 14.8% in a study conducted in a Turkish
population (4), while this rate was 5.9% in the TRA group
in a metaanalysis (5), strongly supporting the findings
obtained from this study.
Coronary interventions performed through the TFA
carry a risk of entry point complications ranging between
1.4% and 23% (1–3). This situation may become particularly
more important in those patients with concomitant use of
thrombolytic therapy, Gp IIb/IIIa inhibitors, and other
antiaggregants or anticoagulants. Some recent studies and
a metaanalysis of 23 randomized controlled studies have
clearly shown the superiority of the TRA to brachial and
femoral approaches in terms of major access site, major
bleeding, and vascular complications (5,7,16). Similarly,
long-term warfarin therapy is presumed to increase the
bleeding and access point complications after coronary
procedures, and thus it is often recommended to postpone
invasive procedures to reach international normalized ratio
(INR) levels of <1.8. Ziakas et al. prospectively studied the
efficacy and procedural safety of the radial versus femoral
approach for cardiac procedures during uninterrupted
warfarin therapy, and they concluded that the TRA is as
efficacious and safe as the TFA for diagnostic CAG in fully
anticoagulated patients, but is related with fewer access-site
complications in patients who also undergo PCI (17). In the
present study, 37.9% of all patients had the clinical picture
of ACS, and the vast majority of them received multiple
antiplatelets and anticoagulants, such as ASA, clopidogrel,
and Gp IIb/IIIa inhibitors, while a small portion of
patients with AMI received also thrombolytic therapy
during their transfers to our hospitals. As a side note, only
5 patients with mechanical heart valve(s) had long-term
warfarin management with INR levels between 2 and 3.5.

Whereas none of these patients developed major bleeding
complications, some patients experienced some access
site and vascular complications, such as minor hematoma
and venous thrombosis of an upper extremity. On the
other hand, RAO has been reported to be an important
complication of transradial coronary procedures, with an
incidence of 2%–30% (10,16,18–20). In our study, RAO
was observed to be low, with an incidence of 6.3%. Routine
administration of heparin (5000 IU) immediately after
the transradial puncture and additional doses of heparin
(5000 IU) during the transradial PCI and, if necessary,
intracoronary use of tirofiban may have diminished the
RAO rate. In the early days of transradial procedures,
Spaulding et al. found a RAO rate of 71% without heparin,
24.4% with 2000 to 3000 IU of heparin, and 4.3% with
5000 IU of heparin (21). In addition, the short duration
of cannulation (mean: 22 min) may have contributed to
the low incidence of RAO. Stella et al. investigated the
incidence of RAO in patients who underwent transradial
coronary interventions using 6 F introducer sheaths and 6
F guiding catheters with a short duration of cannulation
(mean: 40 min), and they reported a very low incidence
of RAO at both discharge (5.3%) and 1 month of followup (2.8%) (10), strongly supporting the findings of the
current study.
Neurologic complications have been reported
as a rare but potentially catastrophic complication
following coronary procedures via the TFA (22). The
transradial approach’s value in achieving fewer neurologic
complications after diagnostic coronary angiography and/
or angioplasty has not been elucidated yet. Burzotta et al.,
in their study of >10,000 patients undergoing coronary
diagnostic or interventions procedures with the TRA,
noted that 0.06% had cerebrovascular accidents (0.03%
TIA, 0.03% stroke) (7). A retrospective analysis, in which a
total of 306,716 procedures had been performed either by
TRA or TFA, demonstrated that neurologic complications
occurred in 148 (0.118%) of 125,725 procedures with
TRA and in 180 (0.099%) of 180,991 procedures with TFA
(23). This study concluded that the vascular access site did
not appear to be a predictor of neurologic complications
following coronary intervention. Similar to those results,
we found that 1 (0.25%) patient in our study had a TIA,
with no evidence of hemorrhage or infarction on cerebral
CT and MRI. TIA observed in this patient was ascribed to
a possible microembolic event. All cardiac catheterization
procedures may give rise to microemboli, consisting of
benign microbubbles and atheromatous materials from
the aortic wall. In addition, it is important to note that the
posterior circulation nourishing the functionally crucial
territory of the brain might be more compromised by the
TRA as the vertebral artery originates from the subclavian
artery (24).
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The TRA to PCI tends to be technically extremely
challenging and time-consuming, especially during the
initial learning curve period. This may result in more
prolongation of the door-to-balloon time in patients with
AMI, which is closely associated with mortality rate (25).
The door-to-balloon time was reported as 81 ± 38 min in
a study by Jen et al. (26) and as 76.9 ± 25.9 min in the
RADIAMI study (27). In our study, the mean procedure
time and mean fluoroscopy time for only diagnostic CAG
in the whole study population were 5.6 ± 2.1 min and 2.3 ±
1.4 min, respectively, whereas in patients with AMI, mean
total procedure time was 70 ± 23 min, mean fluoroscopy
time was 15.0 ± 6.1 min, and door-to-balloon time was 62
± 22 min. All procedures times obtained in our study were
shorter than those of the studies described above. Several
factors may have contributed to the emergence of this result.
First, all procedures were implemented by interventional
cardiologists with at least 5 years of experience in radial
interventions. Second, our hospitals and health personnel
are capable of primary PCI within 30–60 min in patients
with AMI. Third, our study did not enroll patients with
cardiogenic shock or hemodynamic instability requiring a
transvenous pacemaker and/or IABP.
The TRA allows early mobilization of patients, which
is especially important to reduce hospital charges and to
improve patient’s comfort. Escarcega et al. showed that the
TRA in coronary procedures is clearly more cost-effective
than the TFA, as a consequence of lower requirements for
medical and nursing staff in patient management, as well
as more rapid return to productivity for working patients
with same-day PCI in the TRA group (28). Moreover,
some recent studies have demonstrated that coronary
interventions with the TRA were associated with shorter
hospital stay when compared to the TFA in a wider

population of patients (29,30). In the current study, we
detected that the length of hospital stay after procedures
was 11.6 ± 8.5 h in the total study population, 4.9 ± 0.6 h in
those with CAG only, and 28.2 ± 12.8 h in those with AMI.
Another important point is whether repetitive
transradial coronary procedures might be performed
using the same route. Many studies related to this topic
have recently shown that repeated transradial coronary
procedures from the same route could be safely and
effectively carried out (31,32). In line with these studies,
we also observed that repetitive transradial CAG and PCI
could be easily and safely applied through the same artery,
with a high procedural success, comparable procedural
times, and no complications.
The most important limitations of the present study
were that it was retrospective and nonrandomized. Another
limitation was the absence of systematic Doppler findings
for determination of asymptomatic radial artery occlusion
and/or any other vascular complications. Consequently,
the rates of vascular complications, such as RAO and
venous thrombosis, may have been underestimated. The
amounts of contrast agent used, and operator radiation
exposure, which may vary according to operator location
and X-ray source, were not estimated.
In conclusion, transradial CAG and/or PCI can be
safely and effectively performed with high success and low
complication rates, provided that it is employed by skilled
operators, in patients with a wide range of CAD, including
AMI, and in particular in hemodynamically stable patients
who do not require IABP or temporary pacemakers. We
also concluded that the TRA may also be alternative
to the TFA for patients who have conditions requiring
chronic warfarin treatment with INR levels of >1.8, such
as prosthetic heart valves.
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